Related references
Note: Only part of the references are listed.Natural products as LSD1 inhibitors for cancer therapy
Yuan Fang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1
Xiangyu Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Targeting LSD1 for acute myeloid leukemia (AML) treatment
Shujing Zhang et al.
PHARMACOLOGICAL RESEARCH (2021)
Annual review of LSD1/KDM1A inhibitors in 2020
Dong-Jun Fu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
Xing-Jie Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Advances in epigenetic therapeutics with focus on solid tumors
Ning Jin et al.
CLINICAL EPIGENETICS (2021)
LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
Clement Agboyibor et al.
JOURNAL OF ONCOLOGY (2021)
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
Wen Juan Tu et al.
CELL DISCOVERY (2021)
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
Dongha Kim et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
Recent progress in surface plasmon resonance based sensors: A comprehensive review
Vasimalla Yesudasu et al.
HELIYON (2021)
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia Models
Alessia Romussi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Macrocyclic Peptides Uncover a Novel Binding Mode for Reversible Inhibitors of LSD1
Jie Yang et al.
ACS OMEGA (2020)
Natural protoberberine alkaloids, identified as potent selective LSD1 inhibitors, induce AML cell differentiation
Zhong-Rui Li et al.
BIOORGANIC CHEMISTRY (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2
Ren-Di Jiang et al.
CELL (2020)
Biological roles of LSD1 beyond its demethylase activity
Feiying Gu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Development and Structural Evaluation of N-Alkylated trans-2-Phenylcyclopropylamine-Based LSD1 Inhibitors
Hideaki Niwa et al.
CHEMMEDCHEM (2020)
Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors
Xinran Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?
Shaun Egolf et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations
Tamara Maes et al.
PLOS ONE (2020)
Letter to the editor: Anti-RAS drugs and SARS-CoV-2 infection
Jingwei Bian et al.
ACTA PHARMACEUTICA SINICA B (2020)
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Denisa Bojkova et al.
NATURE (2020)
The Catalytic-Dependent and -Independent Roles of Lsd1 and Lsd2 Lysine Demethylases in Heterochromatin Formation in Schizosaccharomyces pombe
Bahjat F. Marayati et al.
CELLS (2020)
LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT
Qiubo Xie et al.
FRONTIERS IN ONCOLOGY (2020)
Antiviral Properties of the LSD1 Inhibitor SP-2509
Mitchell R. Harancher et al.
JOURNAL OF VIROLOGY (2020)
Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)
Toufike Kanouni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting LSD1 and FOXA1 in prostate cancer
Soleilmane Omarjee et al.
NATURE GENETICS (2020)
LSD1: more than demethylation of histone lysine residues
Bruno Perillo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
The R251Q mutation of LSD1 promotes invasion andmigration of luminal breast cancer cells
Yu Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Current Trends in Cancer Immunotherapy
Ivan Y. Filin et al.
BIOMEDICINES (2020)
The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration
Amanda K. Engstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin et al.
ONCOGENE (2019)
LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML
Jessica Barth et al.
LEUKEMIA (2019)
Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition
Arnaud Augert et al.
SCIENCE SIGNALING (2019)
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
Barbara Majello et al.
CANCERS (2019)
CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML
Michael E. Vinyard et al.
NATURE CHEMICAL BIOLOGY (2019)
Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
Abel H. Y. Tan et al.
FRONTIERS IN IMMUNOLOGY (2019)
LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression
Xin Hu et al.
ONCOGENE (2019)
What potential is there for LSD1 inhibitors to reach approval for AML?
Manu R. Pandey et al.
EXPERT OPINION ON EMERGING DRUGS (2019)
Recapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice
Jun Mukai et al.
NEURON (2019)
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
Panagiotis Karakaidos et al.
CANCERS (2019)
Ligand-based design, synthesis and biological evaluation of xanthine derivatives as LSD1/KDM1A inhibitors
Qi-Sheng Ma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Yuan Fang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
Zhonghua Li et al.
ACTA PHARMACEUTICA SINICA B (2019)
Surface plasmon resonance imaging validation of small molecule drugs binding on target protein microarrays
Wenfei Zhou et al.
APPLIED SURFACE SCIENCE (2018)
Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis
Chao Han et al.
BIOORGANIC CHEMISTRY (2018)
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1-and C/EBPα-dependent enhancers in AML
Monica Cusan et al.
BLOOD (2018)
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Tamara Maes et al.
CANCER CELL (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
Crystal Structure of LSD1 in Complex with 4-[5-(Piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile
Hideaki Niwa et al.
MOLECULES (2018)
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function
Archana Sehrawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells
Sumati Gupta et al.
Oncotarget (2018)
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
Daniela Magliulo et al.
FRONTIERS IN ONCOLOGY (2018)
Pharmacological Inhibition of LSD1 for Cancer Treatment
Guan-Jun Yang et al.
MOLECULES (2018)
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone
Jonas S. Jutzi et al.
HEMASPHERE (2018)
Advances toward LSD1 inhibitors for cancer therapy
Xiaoli Fu et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
Lars Bullinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration
Luca Sartori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship
Paola Vianello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Development of (4-Cyanophenyl)glycine Derivatives as Reversible Inhibitors of Lysine Specific Demethylase 1
Daniel P. Mould et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions
Maria Larrosa-Garcia et al.
MOLECULAR CANCER THERAPEUTICS (2017)
LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis
J-Y Lee et al.
ONCOGENE (2017)
A comprehensive review of lysine-specific demethylase 1 and its roles in cancer
Amir Hosseini et al.
EPIGENOMICS (2017)
LSD1 protects against hippocampal and cortical neurodegeneration
Michael A. Christopher et al.
NATURE COMMUNICATIONS (2017)
GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1 (vol 473, pg 3355, 2016)
Matthew Velinder et al.
BIOCHEMICAL JOURNAL (2017)
An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors
Yi-Chao Zheng et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1
Yuichi Amano et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1
Fangrui Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1
Roshana Thambyrajah et al.
NATURE CELL BIOLOGY (2016)
Baicalin, a natural LSD1 inhibitor
Yi-Chao Zheng et al.
BIOORGANIC CHEMISTRY (2016)
The growing structural and functional complexity of the LSD1/KDM1A histone demethylase
Chiara Marabelli et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
LSD1 inhibitors: a patent review (2010-2015)
Giulia Stazi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent
Paola Vianello et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocation
Eric Metzger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP
Marcela A. Bennesch et al.
NUCLEIC ACIDS RESEARCH (2016)
Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review
Zhiying Huang et al.
PHARMACOLOGICAL RESEARCH (2016)
Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells
S. Gupta et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Assembly of methylated KDM1A and CHD1 drives androgen receptor-dependent transcription and translocation
Eric Metzger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors
Yi-Chao Zheng et al.
MEDICINAL RESEARCH REVIEWS (2015)
LSD1n is an H4K20 demethylase regulating memory formation via transcriptional elongation control
Jianxun Wang et al.
NATURE NEUROSCIENCE (2015)
LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2
Miki Takeuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions
Toe Kon Kim et al.
SEMINARS IN HEMATOLOGY (2015)
Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes
Federico Andreoli et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery
Simon G. Patching
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms
Dennis Niebel et al.
BLOOD (2014)
Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552
H. Mohammad et al.
EUROPEAN JOURNAL OF CANCER (2014)
Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: A novel class of irreversible inhibitors of histone demethylase KDM1A
Paola Vianello et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2
Emanuela Toffolo et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Differential Properties of Transcriptional Complexes Formed by the CoREST Family
Alvaro P. Barrios et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate
Zigmund Luka et al.
PROTEIN SCIENCE (2014)
Protein Recognition by Short Peptide Reversible Inhibitors of the Chromatin-Modifying LSD1/CoREST Lysine Demethylase
Marcello Tortorici et al.
ACS CHEMICAL BIOLOGY (2013)
High-Throughput Virtual Screening Identifies Novel N′-(1-Phenylethylidene)-benzohydrazides as Potent, Specific, and Reversible LSD1 Inhibitors
Venkataswamy Sorna et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Core Chromatin Remodeling Factor Instructs Global Chromatin Signaling through Multivalent Reading of Nucleosome Codes
Sujit S. Nair et al.
MOLECULAR CELL (2013)
Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components
Andreas Janzer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation
A. Spruessel et al.
LEUKEMIA (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition
Riccardo Baron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Demethylation of RB Regulator MYPT1 by Histone Demethylase LSD1 Promotes Cell Cycle Progression in Cancer Cells
Hyun-Soo Cho et al.
CANCER RESEARCH (2011)
Methylation-mediated regulation of E2F1 in DNA damage-induced cell death
Qi Xie et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2011)
Role of Androgen Receptor and Associated Lysine-Demethylase Coregulators, LSD1 and JMJD2A, in Localized and Advanced Human Bladder Cancer
Eric C. Kauffman et al.
MOLECULAR CARCINOGENESIS (2011)
Molecular Mimicry and Ligand Recognition in Binding and Catalysis by the Histone Demethylase LSD1-CoREST Complex
Riccardo Baron et al.
STRUCTURE (2011)
Structurally Designed trans-2-Phenylcyclopropylamine Derivatives Potently Inhibit Histone Demethylase LSDI/KDM1
Shinya Mimasu et al.
BIOCHEMISTRY (2010)
Surface Plasmon Resonance: An Introduction to a Surface Spectroscopy Technique
Yijun Tang et al.
JOURNAL OF CHEMICAL EDUCATION (2010)
Alternative Splicing of the Histone Demethylase LSD1/KDM1 Contributes to the Modulation of Neurite Morphogenesis in the Mammalian Nervous System
Cristina Zibetti et al.
JOURNAL OF NEUROSCIENCE (2010)
Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2
Claudia Binda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Histone Demethylase LSD1 Regulates Neural Stem Cell Proliferation
GuoQiang Sun et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Lysine Methylation Regulates E2F1-Induced Cell Death
Haroula Kontaki et al.
MOLECULAR CELL (2010)
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Jinbo Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
Jing Wang et al.
NATURE GENETICS (2009)
Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å
Shinya Mimasu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
An epigenetic clue to diabetic vascular disease
Christopher P. Mack
CIRCULATION RESEARCH (2008)
DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression
Bruno Perillo et al.
SCIENCE (2008)
Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1
Shireen Saleque et al.
MOLECULAR CELL (2007)
Structural basis of LSD1-CoREST selectivity in histone H3 recognition
Federico Forneris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine
Maojun Yang et al.
BIOCHEMISTRY (2007)
trans-2-phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1
Dawn M. Z. Schmidt et al.
BIOCHEMISTRY (2007)
Regulation of histone methylation by demethylimination and demethylation
Robert J. Klose et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Crystal structure of human histone lysine-specific demethylase 1 (LSD1)
Yong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase
Maojun Yang et al.
MOLECULAR CELL (2006)
Crystal structure and mechanism of human lysine-specific demethylase-1
Pete Stavropoulos et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis
N Ballas et al.
CELL (2005)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes
MA Hakimi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
CoREST is an integral component of the CoREST-human histone deacetylase complex
A You et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
